$10.47 -0.06 (-0.57%)
2/10/2012 4:00 PM

Affymax, Inc. (NASDAQ:AFFY)

CAPS Rating: 2 out of 5

The Company is a biopharmaceutical company developing novel peptide-based drug candidates to improve the treatment of serious and often life-threatening conditions.

Featured Broker Partners


Advertisement